11 results on '"Encinas V"'
Search Results
2. Primary sciatic nerve lymphoma
- Author
-
Rojas-Marcos, I., Montero-Perea, E., Salinas-Martín, M.V., Encinas, V., Pujol, M., and Martino, M.
- Published
- 2010
- Full Text
- View/download PDF
3. Linfoma primario del nervio ciático
- Author
-
Rojas-Marcos, I., Montero-Perea, E., Salinas-Martín, M.V., Encinas, V., Pujol, M., and Martino, M.
- Published
- 2010
- Full Text
- View/download PDF
4. PERFIL IDENTIFICATIVO DE LAS EMPRESAS DE TURISMO DE AVENTURA EN ESPAÑA, ITALIA Y COSTA RICA.
- Author
-
Mediavilla Saldaña, L., Gómez Encinas, V., Sánchez Burón, A., and Villota Valverde, S.
- Abstract
Copyright of Journal of Sport & Health Research is the property of Journal of Sport & Health Research and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2014
5. Trabectedin Plus Radiotherapy for Advanced Soft-Tissue Sarcoma: Experience in Forty Patients Treated at a Sarcoma Reference Center
- Author
-
David Marcilla, Cristobal Muñoz-Casares, Nadia Hindi, Antonio Gutierrez, Alberto Sánchez-Camacho, Javier Martin-Broto, Sara Chacon, P. Sancho, Paloma Santos, Johanna Benedetti, Paloma Sanchez-Bustos, Javier Peinado, Victor Encinas, Irene Carrasco García, David S. Moura, Inmaculada Rincón, [Hindi,N, Carrasco García,I, Sánchez-Camacho,A, Benedetti,J, Sancho,P, Santos,P, Martin-Broto,J] Medical Oncology Department, Hospital Universitario Virgen del Rocio, Sevilla, Spain. [Hindi,N, Sánchez-Bustos,P, Moura,D, Martin-Broto,J] TERABIS Group, IBiS (Instituto de Biomedicina de Sevilla), Sevilla, Spain. [Gutierrez,A] Hematology Department, University Hospital Son Espases, Mallorca, Spain. [Peinado,J, and Rincón,I] Radiation Oncology Department, University Hospital Virgen del Rocio, Sevilla, Spain. [Peinado,J] Biología Molecular del Cáncer, IBiS (Instituto de Biomedicina de Sevilla), Sevilla, Spain. [Peinado,J] Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain. [Marcilla,D] Pathology Department, Hospital Universitario Virgen del Rocio, Sevilla, Spain. [Encinas,V] Musculoskeletal Unit, Radiology Department, Hospital Universitario Virgen del Rocio, Sevilla, Spain. [Chacon,S] Musculoskeletal Tumor Unit, Orthopedics Surgery Department, Hospital Universitario Virgen del Rocio, Sevilla, Spain. [Muñoz-Casares,C] Surgery Department, Hospital Universitario Virgen del Rocio, Sevilla, Spain.
- Subjects
0301 basic medicine ,Advanced soft tissue sarcomas ,Cancer Research ,Antraciclinas ,Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Epidemiologic Study Characteristics as Topic::Epidemiologic Studies::Case-Control Studies::Retrospective Studies [Medical Subject Headings] ,medicine.medical_treatment ,Trabectedina ,Chemicals and Drugs::Organic Chemicals::Hydrocarbons::Hydrocarbons, Halogenated::Mustard Compounds::Nitrogen Mustard Compounds::Phosphoramide Mustards::Cyclophosphamide::Ifosfamide [Medical Subject Headings] ,Diseases::Neoplasms::Neoplasms by Histologic Type::Neoplasms, Connective and Soft Tissue::Sarcoma [Medical Subject Headings] ,Diseases::Respiratory Tract Diseases::Respiration Disorders::Dyspnea [Medical Subject Headings] ,Analytical, Diagnostic and Therapeutic Techniques and Equipment::Therapeutics::Patient Care::Palliative Care [Medical Subject Headings] ,trabectedin plus radiotherapy ,Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans [Medical Subject Headings] ,0302 clinical medicine ,advanced soft-tissue sarcoma ,Anatomy::Cells::Cells, Cultured::Cell Line [Medical Subject Headings] ,Anthracyclines ,Trabectedin ,Palliative therapy ,Soft tissue sarcoma ,Analytical, Diagnostic and Therapeutic Techniques and Equipment::Therapeutics::Radiotherapy [Medical Subject Headings] ,Sarcoma ,Chemicals and Drugs::Organic Chemicals::Hydrocarbons::Hydrocarbons, Cyclic::Hydrocarbons, Aromatic::Polycyclic Hydrocarbons, Aromatic::Naphthacenes::Anthracyclines [Medical Subject Headings] ,lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,Cuidados paliativos ,growth-modulation index ,Oncology ,030220 oncology & carcinogenesis ,medicine.drug ,medicine.medical_specialty ,palliative therapy ,lcsh:RC254-282 ,Article ,03 medical and health sciences ,Radioterapia ,Advanced soft-tissue sarcoma ,Anatomy::Cells::Connective Tissue Cells::Macrophages [Medical Subject Headings] ,Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Epidemiologic Study Characteristics as Topic::Epidemiologic Studies::Cohort Studies::Longitudinal Studies::Follow-Up Studies [Medical Subject Headings] ,medicine ,In patient ,Ifosfamide ,Growth-modulation index ,Persons::Persons::Age Groups::Adult [Medical Subject Headings] ,Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Radiation-Sensitizing Agents [Medical Subject Headings] ,business.industry ,Ifosfamida ,Diseases::Pathological Conditions, Signs and Symptoms::Signs and Symptoms::Pain [Medical Subject Headings] ,Trabectedin plus radiotherapy ,medicine.disease ,Symptomatic relief ,Surgery ,Clinical trial ,Radiation therapy ,Regimen ,030104 developmental biology ,Dyspnea ,Disnea ,business - Abstract
Symptomatic control and tumoral shrinkage is an unmet need in advanced soft-tissue sarcoma (STS) patients beyond first-line. The combination of trabectedin and radiotherapy showed activity in a recently reported clinical trial in this setting. This retrospective series aims to analyze our experience with the same regimen in the real-life setting. We retrospectively reviewed advanced sarcoma patients treated with trabectedin concomitantly with radiotherapy with palliative intent. Growth-modulation index (GMI) was calculated as a surrogate of efficacy. Forty metastatic patients were analyzed. According to RECIST, there was one (2.5%) complete response, 12 (30%) partial responses, 18 (45%) disease stabilizations, and nine (22.5%) progressions. After a median follow-up of 15 months (range 2&ndash, 38), median progression-free survival (PFS) and overall survival (OS) were 7.5 months (95% CI 2.8&ndash, 12.2) and 23.5 months (95% CI 1.1&ndash, 45.8), respectively. Median GMI was 1.42 (range 0.19&ndash, 23.76), and in 16 (53%) patients, it was >, 1.33. In patients with GMI >, 1.33, median OS was significantly longer than in those with GMI 0&ndash, 1.33 (median OS 52.1 months (95% CI not reached) vs. 8.9 months (95% CI 6.3&ndash, 11.6), p = 0.028). The combination of trabectedin plus radiotherapy is an active therapeutic option in patients with advanced STS, especially when tumor shrinkage for symptomatic relief is needed.
- Published
- 2020
6. Seabirds as biovectors in the transport of plastic debris across ecosystem borders: A case study from the Humboldt Current Upwelling System.
- Author
-
Fernández CE, Luna-Jorquera G, González Encinas V, Auger Lancelloti A, Lantadilla C, Aguilar-Pulido R, Kiessling T, Knickmeier K, Varela AI, and Thiel M
- Subjects
- Animals, Chile, Charadriiformes physiology, Waste Products analysis, Water Pollutants, Chemical analysis, Microplastics analysis, Plastics analysis, Environmental Monitoring, Ecosystem, Birds
- Abstract
Seabirds have become biovectors of plastic pollutants between marine and terrestrial ecosystems, and transport of plastics to their nesting sites becomes relevant due to increasing levels of pollution. To determine the pathways by which plastic reaches their colonies, we analysed the abundance of plastics at the nesting sites of five seabird species (Humboldt penguin Spheniscus humboldti, Peruvian booby Sula variegata, kelp gull Larus dominicanus, grey gull Leucophaeus modestus, Markham's storm-petrel Hydrobates markhami) nesting in northern Chile. Seabirds were primarily grouped according to their nesting behaviour, but two species foraging in contrasting habitats (kelp gull and Markham's storm-petrel) were also compared directly. The abundance, type, and polymer of macro-, meso- and microplastics were analysed in the soil of colonies and control sites, and microplastic ingestion was evaluated for selected species. Densities of plastics in colonies of surface-nesting seabirds ranged from 0 to 21.4 items m
-2 (mainly plastic bags and thin films), and 0.002 to 19.7 items m-2 (mainly hard fragments) in colonies of burrow-nesting seabirds. Mean microplastic loads in the stomachs of seabirds were between 3.7 ± 4.2 plastic items individual-1 . Overall, the abundances of plastic items in all seabird colonies were low, suggesting a limited transfer of plastics from sea to land. For kelp gulls, the results indicate transfer of macroplastic items to colonies, reaching the colony via regurgitates, with landfills considered as the main plastic source. Our results suggest that contrasting nesting behaviour and foraging habitats among species can explain differential plastic accumulation in seabird colonies, but also other factors, such as wind, contribute to the accumulation of plastic debris in colonies. Proper management of sanitary landfills are key to reduce plastic contamination of coastal seabirds and their colonies., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 Elsevier B.V. All rights reserved.)- Published
- 2024
- Full Text
- View/download PDF
7. Physical Compatibility Between Intravenous Magnesium Sulfate and Potassium or Sodium Phosphate in a Pediatric Intensive Care Unit.
- Author
-
Clemente Bautista S, Jiménez Lozano I, Castellote Belles L, Parramón-Teixidó CJ, Garcia Esquerda C, Puertas Sanjuan A, Daina Noves C, Segura Encinas V, and Cabañas Poy MJ
- Abstract
Objective: To evaluate the physical compatibility between intravenous magnesium sulfate and potassium and sodium phosphate, a common electrolyte intravenous supplementation in pediatric intensive care units. Study design: Magnesium sulfate was mixed separately with potassium phosphate and sodium phosphate at ratios of 1:1, 1:4, and 4:1. Binary mixtures were prepared, in triplicate and under sterile conditions, by permuting the order of addition. The undiluted pure drugs were used as controls for possible sequence effects. Visual changes, turbidity, and pH were assessed immediately after mixing (baseline) and at 4 and 24 hours. Two observers performed visual changes by naked-eye visual inspection in order to search visible haze, particulate matter, gas formation, or color change. Turbidity was measured by nephelometry and incompatibility was defined as an increase of ≥0.5 nephelometric turbidity units (NTU) from baseline. pH was measured using a portable pH meter and incompatibility was defined as a variation of >1 pH unit during the observation period. Results: None of the admixtures exhibited visual changes or significant variations in turbidity (increases of ≥0.5 in nephelometric turbidity units) or pH (changes of >1 unit) during the observation period and neither compared with baseline. Conclusion: In this study, no visual changes were observed, and turbidity and pH evaluated by instrumental methods remained within acceptable limits and showed no significant variations from baseline, therefore no physical incompatibility between magnesium sulfate and potassium or sodium phosphate was found., Competing Interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article., (© The Author(s) 2024.)
- Published
- 2024
- Full Text
- View/download PDF
8. The Disease Progression and Molecular Defense Response in Chenopodium Quinoa Infected with Peronospora Variabilis , the Causal Agent of Quinoa Downy Mildew.
- Author
-
Rollano-Peñaloza OM, Palma-Encinas V, Widell S, Mollinedo P, and Rasmusson AG
- Abstract
Downy mildew disease, caused by the biotrophic oomycete Peronospora variabilis , is the largest threat to the cultivation of quinoa ( Chenopodium quinoa Willd.) in the Andean highlands, and occurs worldwide. However, so far, no molecular study of the quinoa- Peronospora interaction has been reported. Here, we developed tools to study downy mildew disease in quinoa at the gene expression level. P. variabilis was isolated and maintained, allowing the study of downy mildew disease progression in two quinoa cultivars under controlled conditions. Quinoa gene expression changes induced by P. variabilis were analyzed by qRT-PCR, for quinoa homologues of A. thaliana pathogen-associated genes. Overall, we observed a slower disease progression and higher tolerance in the quinoa cultivar Kurmi than in the cultivar Maniqueña Real. The quinoa orthologs of putative defense genes such as the catalase CqCAT2 and the endochitinase CqEP3 showed no changes in gene expression. In contrast, quinoa orthologs of other defense response genes such as the transcription factor CqWRKY33 and the chaperone CqHSP90 were significantly induced in plants infected with P. variabilis . These genes could be used as defense response markers to select quinoa cultivars that are more tolerant to P. variabilis infection.
- Published
- 2022
- Full Text
- View/download PDF
9. Erratum: Hindi, N., et al. Trabectedin Plus Radiotherapy for Advanced Soft-Tissue Sarcoma: Experience in Forty Patients Treated at a Sarcoma Reference Center. Cancers 2020, 12 , 3740.
- Author
-
Hindi N, García IC, Sánchez-Camacho A, Gutierrez A, Peinado J, Rincón I, Benedetti J, Sancho P, Santos P, Sánchez-Bustos P, Marcilla D, Encinas V, Chacon S, Muñoz-Casares C, Moura D, and Martin-Broto J
- Abstract
The authors noticed that content of "Conflicts of Interest" in the original version [...].
- Published
- 2021
- Full Text
- View/download PDF
10. Trabectedin Plus Radiotherapy for Advanced Soft-Tissue Sarcoma: Experience in Forty Patients Treated at a Sarcoma Reference Center.
- Author
-
Hindi N, Carrasco García I, Sánchez-Camacho A, Gutierrez A, Peinado J, Rincón I, Benedetti J, Sancho P, Santos P, Sánchez-Bustos P, Marcilla D, Encinas V, Chacon S, Muñoz-Casares C, Moura D, and Martin-Broto J
- Abstract
Symptomatic control and tumoral shrinkage is an unmet need in advanced soft-tissue sarcoma (STS) patients beyond first-line. The combination of trabectedin and radiotherapy showed activity in a recently reported clinical trial in this setting. This retrospective series aims to analyze our experience with the same regimen in the real-life setting. We retrospectively reviewed advanced sarcoma patients treated with trabectedin concomitantly with radiotherapy with palliative intent. Growth-modulation index (GMI) was calculated as a surrogate of efficacy. Forty metastatic patients were analyzed. According to RECIST, there was one (2.5%) complete response, 12 (30%) partial responses, 18 (45%) disease stabilizations, and nine (22.5%) progressions. After a median follow-up of 15 months (range 2-38), median progression-free survival (PFS) and overall survival (OS) were 7.5 months (95% CI 2.8-12.2) and 23.5 months (95% CI 1.1-45.8), respectively. Median GMI was 1.42 (range 0.19-23.76), and in 16 (53%) patients, it was >1.33. In patients with GMI >1.33, median OS was significantly longer than in those with GMI 0-1.33 (median OS 52.1 months (95% CI not reached) vs. 8.9 months (95% CI 6.3-11.6), p = 0.028). The combination of trabectedin plus radiotherapy is an active therapeutic option in patients with advanced STS, especially when tumor shrinkage for symptomatic relief is needed.
- Published
- 2020
- Full Text
- View/download PDF
11. [Primary sciatic nerve lymphoma].
- Author
-
Rojas-Marcos I, Montero-Perea E, Salinas-Martín MV, Encinas V, Pujol M, and Martino M
- Subjects
- Aged, 80 and over, Biopsy, Fatal Outcome, Humans, Lymphoma diagnosis, Male, Sciatic Neuropathy diagnosis, Lymphoma pathology, Sciatic Nerve pathology, Sciatic Neuropathy pathology
- Published
- 2010
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.